Cargando…
Synthesis and Optimization of Mesoporous Silica Nanoparticles for Ruthenium Polypyridyl Drug Delivery
The ruthenium polypyridyl complex [Ru(dppz)(2)PIP](2+) (dppz: dipyridophenazine, PIP: (2-(phenyl)-imidazo[4,5-f ][1,10]phenanthroline), or Ru-PIP, is a potential anticancer drug that acts by inhibiting DNA replication. Due to the poor dissolution of Ru-PIP in aqueous media, a drug delivery agent wou...
Autores principales: | Harun, Siti Norain, Ahmad, Haslina, Lim, Hong Ngee, Chia, Suet Lin, Gill, Martin R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7910993/ https://www.ncbi.nlm.nih.gov/pubmed/33498795 http://dx.doi.org/10.3390/pharmaceutics13020150 |
Ejemplares similares
-
A ruthenium polypyridyl intercalator stalls DNA replication forks, radiosensitizes human cancer cells and is enhanced by Chk1 inhibition
por: Gill, Martin R., et al.
Publicado: (2016) -
Corrigendum: A ruthenium polypyridyl intercalator stalls DNA replication forks, radiosensitizes human cancer cells and is enhanced by Chk1 inhibition
por: Gill, Martin R., et al.
Publicado: (2016) -
Discovery of
Ruthenium(II) Metallocompound and Olaparib
Synergy for Cancer Combination Therapy
por: Yusoh, Nur Aininie, et al.
Publicado: (2023) -
Progress in Mesoporous Silica Nanoparticles as Drug Delivery Agents for Cancer Treatment
por: Mohamed Isa, Eleen Dayana, et al.
Publicado: (2021) -
Ruthenium(II)
Polypyridyl Complexes as FRET Donors:
Structure- and Sequence-Selective DNA-Binding and Anticancer Properties
por: Elgar, Christopher E., et al.
Publicado: (2023)